Researchers from Tehran University of Medical Sciences, in collaboration with scientists from the Royan Institute, University of Science and Culture (Iran), and De Montfort University (UK), have successfully developed a new generation of smart, size- and charge-switchable nanocarriers capable of delivering the chemotherapy drug doxorubicin (DOX) deep into brain tumor tissue.